Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Cancer Immunol Immunother. 2020 Feb 8;69(5):731–744. doi: 10.1007/s00262-020-02504-z

Fig 6.

Fig 6

Simulated minimum tumor radius achieved by the MSV-nab-PTX bolus injection for three treatment protocols in the case of an M1:M2 ratio of 3.0:1. Simulation results (n=5, mean±SD) are shown for single dose, administration every 3d, and administration every 2d. (*p< 0.05).